QuiVad

Home / Netherlands / Pharming Group N.V.

Pharming Group N.V.

Short position disclosed on October 22, 2026.

Follow

Evolution of the disclosed total

0%2.5%5%7.5%10%
Jan 2026Apr 2026Jul 2026Oct 2026
Sum of open short positions, asĀ % of capital. Hover or tap the curve to see which funds make it up.
Over the whole history, the total peaked at 8.84% on July 30, 2026. The shaded band matches the twelve months of the first chart.

January 23, 2014 today

Open positions

The funds disclosing a short position that is still open.
FundTwelve months% of capitalOver the yearSince
Two Sigma Investments, LP1.49%newOctober 22, 2026
Citadel Advisors LLC1.34%+0.11 ptOctober 22, 2026
D. E. Shaw & Co., L.P.1.03%newOctober 22, 2026
Citadel Securities (Europe) Limited0.80%newOctober 22, 2026
Capstone Volatility Master (Cayman) Limited0.72%-0.23 ptSeptember 11, 2026
Walleye Capital LLC0.69%newOctober 22, 2026
Whitebox Advisors LLC0.58%-0.02 ptJune 3, 2026
Spark Investment Management LLC0.52%newJune 19, 2026
Jupiter Asset Management Ltd.0.51%newSeptember 11, 2026
AQR Capital Management, LLC0.50%newOctober 8, 2026

In the United States PHGUF (OTC): 10,796,948 shares sold short on September 30, 2026. FINRA names no fund.

On the other side: the funds that hold Pharming Group N.V. Titelia

Follow by RSS

Get the moves on Pharming Group N.V. by mail, at most once a day.

There is no account to create. You give an address, you confirm it through a link, and every message contains a link to stop.

History of disclosures

1,161 disclosures on record for this share.
DateFund% of capitalEnd of publication
July 30, 2020Citadel Advisors LLC1.03%
July 30, 2020Woodline Partners0.79%
July 29, 2020Citadel Advisors LLC0.90%
July 27, 2020Woodline Partners0.60%
July 24, 2020Citadel Advisors LLC0.81%
July 20, 2020Citadel Advisors LLC0.79%
July 20, 2020Woodline Partners0.51%
July 16, 2020Pictet Asset Management Limited0.93%
July 14, 2020Citadel Advisors LLC0.84%
July 7, 2020Citadel Advisors LLC0.71%
July 6, 2020Citadel Advisors LLC0.69%
June 26, 2020Citadel Advisors LLC0.59%
June 16, 2020Citadel Advisors LLC0.60%
June 11, 2020Linden Advisors LP1.18%
June 9, 2020Citadel Advisors LLC0.53%
April 30, 2020Linden Advisors LP1.26%
April 30, 2020Citadel Advisors LLC0.37%
April 29, 2020Citadel Advisors LLC0.59%
April 28, 2020Citadel Advisors LLC0.67%
April 21, 2020Linden Advisors LP1.18%
April 20, 2020Woodline Partners0.48%
April 17, 2020Citadel Advisors LLC0.70%
April 16, 2020Citadel Advisors LLC0.62%
April 15, 2020Citadel Advisors LLC0.56%
March 25, 2020Point72 Asset Management, L.P.0.44%
March 24, 2020Woodline Partners0.58%
March 23, 2020Point72 Asset Management, L.P.0.60%
March 20, 2020Pictet Asset Management Limited0.88%
March 19, 2020Woodline Partners0.76%
March 18, 2020Pictet Asset Management Limited0.99%
March 18, 2020Point72 Asset Management, L.P.0.76%
March 17, 2020Woodline Partners0.81%
March 17, 2020Kingdon Capital Management LLC0.31%
March 16, 2020Point72 Asset Management, L.P.0.88%
March 13, 2020Great Point Partners, LLC1.90%
March 13, 2020Point72 Asset Management, L.P.0.94%
March 13, 2020Woodline Partners0.93%
March 13, 2020Kingdon Capital Management LLC0.68%
March 12, 2020Pictet Asset Management Limited1.07%
March 11, 2020Woodline Partners1.01%
March 6, 2020Pictet Asset Management Limited1.19%
March 5, 2020Linden Advisors LP1.26%
March 3, 2020Linden Advisors LP1.32%
March 3, 2020Point72 Asset Management, L.P.1.02%
March 2, 2020Linden Advisors LP1.26%
February 27, 2020Point72 Asset Management, L.P.0.96%
February 26, 2020Linden Advisors LP1.32%
February 26, 2020Woodline Partners1.10%
February 25, 2020Point72 Asset Management, L.P.1.00%
February 20, 2020Woodline Partners1.01%

Download 1,161 filings as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats

Other companies sold short in the Netherlands

Cite this page

The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.

QuiVad, Pharming Group N.V., source AFM, data as at October 22, 2026, https://www.quivad.com/action/pharming-group-n-v?page=18